Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 5, 2017 – The FDA approved an update to the Warnings and Precautions section of the Zosyn(piperacillin/tazobactam) drug label, regarding nephrotoxicity in critically ill patients.
Return to publications